Abstract

BackgroundTriple therapy (telaprevir/pegylated interferon/ribavirin), is the treatment of choice in patients with genotype 1 chronic hepatitis C virus (HCV). Triple therapy (TT) requires active participation by the hospital pharmacist, because...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
Pratima Sharma ... Anna S Lok
Gastroenterology | VOL. 141
Pratima Sharma, et. al.Pratima Sharma ... Anna S Lok
25 Oct 2011
Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
A Sidney Barritt ... Michael W Fried
Gastroenterology | VOL. 142
A Sidney Barritt, et. al.A Sidney Barritt ... Michael W Fried
23 Apr 2012
A new era for hepatitis C-new diagnostics tools and new weapons.
Vicente Soriano
ACS medicinal chemistry letters | VOL. 3
Vicente SorianoVicente Soriano
03 May 2012
PS-072 Incidence, management and cost of Telaprevir/Boceprevir-Induced thrombocytopenia during the first 12 weeks of treatment in patients with hepatitis C
S Gómez-Álvarez ... J Ventura-Cerdá
-
S Gómez-Álvarez, et. al.S Gómez-Álvarez ... J Ventura-Cerdá
01 Mar 2015
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions
Alena Pilková ... Martin Matoulek
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Alena Pilková, et. al.Alena Pilková ... Martin Matoulek
17 Jul 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management
Giulia Cancellieri ... Piera Polidori
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Giulia Cancellieri, et. al.Giulia Cancellieri ... Piera Polidori
15 Jul 2024
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?
Tien Thuy Ngo ... Charis Lau
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Tien Thuy Ngo, et. al.Tien Thuy Ngo ... Charis Lau
13 Jul 2024
View more papers